| CAS No. | CATO-C4X-1131138 |
| Molecular Formula | C16H9BrS2 |
| Molecular Weight | 345.28 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Brexpiprazole Impurity 138 (CAS CATO-C4X-1131138) is a certified pharmaceutical impurity reference standard with the molecular formula C16H9BrS2 and a molecular weight of 345.28 g/mol.
The molecular framework of Brexpiprazole Impurity 138 (C16H9BrS2) is characterized by sulfur-containing functionality, bromine substitution, a polycyclic aromatic system. In reversed-phase chromatography, its retention is governed primarily by its high hydrophobicity (logP), which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Brexpiprazole Impurity 138 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
| Molecular Formula | C16H9BrS2 |
| Molecular Weight | 345.28 g/mol |
| Purity | >95% |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 12.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | Br-containing |
| Sulfur Atoms | 2 |